Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine sublingual versus mouthwash for clozapine-induced hypersalivation
TCTR20260918012Phase 4Not yet recruiting
- Sponsor
- N/A
- Start
- Oct 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atropine in clozapine-induced hypersalivation (CIS), sponsored by N/A. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
clozapine-induced hypersalivation (CIS)
Beyond the preview
Go deeper on TCTR20260918012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260918012.